Paxil Lawyers

How do Stock Prices, Pharmaceutical Advances Mix?

When viewed in a vacuum, the world of pharmaceutical research is something we should all be rooting for zealously. The more we learn and refine in the world of medicine, the more we'll be able to overcome diseases that have historically been horribly damaging on the human race as a whole. Given the general public's interest in overcoming these challenges, pharmaceutical companies began to grow and grow and grow.

When companies such as GlaxoSmithKline, Eli Lilly, and Company and the like began to go public, they experienced an influx of cash that was hopefully going to be substantially earmarked for research and development, the lifeblood of the pharmaceutical industry. In theory, these were positive developments. In practice, problems have developed with stock offerings being available for ownership in pharmaceutical companies. We'll examine a few of those issues below.

Who's the Boss?

Researchers are a bit of a unique breed - running around in lab coats, working with other scientists and mice and other small animals - and they tend to do their best work when left alone to study, experiment and learn. However, the lead researcher is not the ultimate boss in a pharmaceutical company anymore. The stockholder is now the ultimate boss, and the value of said stock, like with any public company, goes a long way in determining what the priorities for said company are going to be. In order to protect the stock price, budgets have been slashed and workforces have been downsized in recent years. Is this a good thing?

Where's the Money?

Based partially on the success of these pharmaceutical companies, more and more money is being spent on prescription medication than ever before, to the point where the pharmaceutical industry is now a multi-billion dollar market. That's multi-billion in terms of every single year, not just throughout history.

That's enormous money, and when there's that much money on the line and a stock price to protect, competition becomes fierce. When competing in our economy, one of the main ways to do so is with marketing. Pharmaceutical firms as of now spend millions upon millions of dollars for advertising, and one only needs to turn on the television to completely understand this development. Instead of the bulk of money going towards research, it's being spent on commercials and visual advertising. Is that a good thing?

Where Next?

There's no telling what will happen with the pharmaceutical industry going forward. As of now, all we can do is hold these companies accountable when they release products that cause harm. If that includes you, and drugs like Paxil have been the cause, contact the Paxil lawyers at Williams Kherkher to schedule a free initial consultation.